INS and obesity due to melanocortin 4 receptor deficiency: Therefore, it is important to assess the performance of biomarkers of insulin sensitivity in the absence of hyperglycaemia, before inflammation and other obesity-related impairments of metabolism appear, in order to adequately evaluate the initial stages and directionality of the relation between the proposed biomarkers with insulin sensitivity.